Funding Details
- Awarder
- RSS - feeds.feedburner.com
- Date Award
- May 19, 2025
- Vertical
- Oncology
- Funding URL
- View Funding Page
Company Info
- Traction
- The funds will support a Phase 2B randomized controlled trial (RCT) evaluating the efficacy of SDT in patients with newly diagnosed glioblastoma (GBM).
- Company Description
- Alpheus Medical is a private, clinical-stage oncology company pioneering sonodynamic therapy (SDT) for the treatment of solid body cancers. The company is developing a non-invasive treatment utilizing a proprietary platform that combines Low-Intensity Diffuse Ultrasound (LIDU™) with oral 5-aminolevulinic acid (5-ALA) to selectively target and destroy cancer cells while sparing healthy tissue.
- Market
- Cancer treatment
- Location
-
Chanhassen,
Minnesota,
USA
- Coinvestors
- HealthQuest Capital, Samsara BioCapital, OrbiMed, Action Potential Venture Capital, BrightEdge, Brain Tumor Investment Fund, Sontag Innovation Fund
Links